Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) ("Troilus” or the "Company”), is pleased to provide a recap of its ...

The cryptocurrency space is always in the headlines, and almost always for good reasons like a heavy rate of return. Elon ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

When Gloria Kopp got fed up with diet after diet that just didn't work, she took the advice of a friend who'd slimmed down with a commercial diet plan called the Medi-Weightloss Program.

On December 17, 2024, the Office of Fossil and Carbon Management of the Department of Energy (“DOE”) released the long-awaited Liquefied Natural ...

The lack of attraction for new entrants is recognized by the government, and so the government has not sought to open up the power market to others—as such, we think CLP’s moat is based on an ...

THISDAY has honoured D’Tigress as Sports Personality of the Year and unveiled nominees for Game Changer and Lifetime Achievements categories ...